H. Ren

发表

Design and synthesis of novel pyrazolo[1,5-a]pyrimidine derivatives bearing nitrogen mustard moiety and evaluation of their antitumor activity in vitro and in vivo.

Huabei Zhang, Mingxia Zhao, H. Ren, 2016, European journal of medicinal chemistry.

Evaluation of 18F-labeled icotinib derivatives as potential PET agents for tumor imaging

Mingxia Zhao, H. Ren, Jin Chang, 2016, Journal of Radioanalytical and Nuclear Chemistry.

Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4B.

Z. Gu, C. Espiritu, H. Ren, 2013, Bioorganic & Medicinal Chemistry Letters.

Design, synthesis, and biological evaluation of a series of simple and novel potential antimalarial compounds.

V. Yardley, S. Croft, H. Ren, 2001, Bioorganic & medicinal chemistry letters.

6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4B.

Z. Gu, H. Ren, A. Nomeir, 2015, Bioorganic & medicinal chemistry letters.

Unexpected Observation of the Dimroth Rearrangement in the Ribosylation of 4-Aminopyrimidines.

H. Ren, Y. Moon, N. Sydorenko, 2017, The Journal of organic chemistry.

Design, synthesis, and biological evaluation of a series of simple and novel potential antimalarial compounds.

V. Yardley, S. Croft, H. Ren, 2001, Bioorganic & medicinal chemistry letters.

Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.

Huabei Zhang, Mingxia Zhao, H. Ren, 2017, European journal of medicinal chemistry.

A coumarin-based reversible fluorescent probe for Cu2+ and S2− and its applicability in vivo and for organism imaging

H. Ren, Mengmeng Huang, Jichao Chen, 2021 .

Structure-activity relationship (SAR) optimization of 6-(indol-2-yl)pyridine-3-sulfonamides: identification of potent, selective, and orally bioavailable small molecules targeting hepatitis C (HCV) NS4B.

Ramesh Kakarla, Guangming Chen, Song Huang, 2014, Journal of medicinal chemistry.

PTC124 targets genetic disorders caused by nonsense mutations

Meenal Patel, Feng He, Masataka Kawana, 2007, Nature.

The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential

S. Peltz, Jairo L. Sierra, H. Ren, 2018, PloS one.

Synthesis and in vitro anti-protozoal activity of a series of benzotropolone derivatives incorporating endocyclic hydrazines.

V. Yardley, S. Croft, H. Ren, 2003, European journal of medicinal chemistry.

Discovery of N-(4'-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replication.

Z. Gu, H. Ren, J. Colacino, 2013, Bioorganic & medicinal chemistry letters.